Nonclinical Pharmacokinetics and Activity of Etirinotecan Pegol (NKTR-102), a Long-Acting Topoisomerase 1 Inhibitor, in Multiple Cancer Models

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-014-2577-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search